KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 103 filers reported holding KYMERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,845,441 | -63.8% | 204,708 | -40.1% | 0.00% | -50.0% |
| Q2 2023 | $7,852,120 | -10.7% | 341,545 | +15.1% | 0.00% | 0.0% |
| Q1 2023 | $8,795,458 | +4.3% | 296,843 | -12.2% | 0.00% | 0.0% |
| Q4 2022 | $8,434,733 | +15.1% | 337,930 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $7,331,000 | +34.3% | 336,759 | +21.5% | 0.00% | +100.0% |
| Q2 2022 | $5,459,000 | -47.1% | 277,264 | +13.7% | 0.00% | -50.0% |
| Q1 2022 | $10,323,000 | -39.3% | 243,926 | -8.9% | 0.00% | -33.3% |
| Q4 2021 | $17,002,000 | +60.6% | 267,790 | +48.6% | 0.00% | +50.0% |
| Q3 2021 | $10,585,000 | +172.7% | 180,207 | +125.3% | 0.00% | +100.0% |
| Q2 2021 | $3,881,000 | +589.3% | 80,003 | +451.9% | 0.00% | – |
| Q1 2021 | $563,000 | -67.5% | 14,496 | -48.1% | 0.00% | – |
| Q4 2020 | $1,732,000 | -63.7% | 27,930 | -81.1% | 0.00% | -100.0% |
| Q3 2020 | $4,773,000 | – | 147,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |